The Stanford Neuro-Oncology Program Adult Clinical Trials

Newly Diagnosed Glioma

A Follow-Up Study to Add Whole Brain Radiotherapy (WBRT) to Standard Temozolomide Chemo-Radiotherapy in Newly Diagnosed Glioblastoma (GBM) Treated with 4 Weeks of Continuous Infusion Plerixafor
PI: Lawrence Recht
Co-PI: Reena Thomas NCT03746080

Recurrent High Grade Glioma

ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
PI: Reena Thomas NCT03295396

TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PI: Seema Nagpal NCT03856099

CNS Diagnostic Imaging

Phase I/II, Open-Label Study Evaluating the Efficacy and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms during Neurosurgical Procedure
PI: Gordon Li NCT03510208

A Phase I Study of [18F]DASA-23 as a PET Tracer for Evaluating Pyruvate Kinase M2 (PKM2) Expression in Healthy Volunteers and in Patients with Intracranial Tumors
PI: Sanjiv Gambhir NCT03539731

A Pilot Study to Assess Lactate and Bicarbonate Detection Within Malignant Brain Tumors Using [1-13C]-Pyruvate DNP Magnetic Resonance Spectroscopy (MRS)
PI: Lawrence Recht NCT03565367

Clinical Trials

Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.


Sophie Bertrand, CCRP
Clinical Research Manager / Neuro-Oncology / Head and Neck / Cancer Clinical Trials Office